Navigation Links
VIA Pharmaceuticals Set to Join Russell Microcap Index
Date:6/27/2008

ome cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to:

-- our ability to obtain necessary financing;

-- our ability to control our operating expenses;

-- our ability to recruit and enroll patients for the FDG-PET clinical

trial;

-- failure to obtain sufficient data from enrolled patients that can be

used to evaluate VIA-2291, thereby impairing the validity or

statistical significance of our clinical trials;

-- our ability to successfully complete our clinical trials of VIA-2291 on

expected timetables and the outcomes of such clinical trials;

-- complexities in designing and implementing cardiovascular clinical

trials using histological examinations, measurement of biomarkers,

medical imaging and atherosclerotic plaque bioassays;

-- the results of our clinical trials, including without limitation, with

respect to the safety and efficacy of VIA-2291;

-- the outcome of any legal proceedings;

-- our ability to obtain necessary FDA approvals;

-- our ability to successfully commercialize VIA-2291;

-- our ability to obtain and protect our intellectual property related to

our product candidates;

-- our potential for future growth and the development of our product

pipeline;

-- our ability to form and maintain collaborative relationships to develop

and commercialize our product candidates;

-- general economic and business conditions; and

-- the other risks described under Item IA "Risk Factors" in our Annual

Report on Form 10-K for the fiscal year ended December 31, 2007 on file

with the SEC.

All forward-looking statements attributable to us or persons acting on our be
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Wyeth Pharmaceuticals Announces Organizational Change
2. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
3. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
4. Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
5. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
6. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
7. Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
8. Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
9. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
10. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
11. Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 03, 2015 Marktech Optoelectronics is pleased ... Marktech APD’s have an internal gain mechanism, fast time ... near infrared region. These APD’s are recommended for applications ... needed to overcome high pre-amp noise. In addition, Marktech ... are ideal for extreme low-level light detection and short ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 From smart ... an important part in enabling success in dealing with ... and technology leaders helped bring focus to the role ... the Photonics21 annual meeting last week in ... the event, held 28 and 29 May at the ...
(Date:6/2/2015)... MIAMI (PRWEB) June 02, 2015 Global ... Latin America distributor for Bioquark, Inc.’s biologic products for the ... is the latest in Global Stem Cells Group’s ambitious expansion ... region’s growing demand for access to regenerative medicine and stem ... on the development of biologics that have the ability to ...
(Date:6/2/2015)... , June 02, 2015 Research ... of Jain PharmaBiotech,s new report "Biomarkers - ... This report follows the broad definition ... be objectively measured and evaluated as an indicator ... as pharmacological responses to a therapeutic intervention. Tests ...
Breaking Biology Technology:Marktech Introduces New Line of APDs 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 3Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 2Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 3Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 2Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 3
... /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc.,("Dragon" or the "Company" TSX: DDD; OTCBB: ... results,for the fiscal year ended December 31, 2007., 2007 ... to $85.8 million from $52.4 million in 2006 ... $68.9 million from ...
... New Technologies and Expanded Reach Across Europe Help Customers to Move ... ... Inc. (NYSE: TMO ), the world leader in serving science, today,launched ... technology tradeshow, taking place in Munich, Germany,from April 1 - 4. The ...
... Varian, Inc.,(NasdaqGS: VARI) announced today the release ... gas chromatography (GC), which is resistant to,damage ... columns,allow chemists to confidently analyze samples at ... Based on a stainless steel capillary, Varian,s,UltiMetal ...
Cached Biology Technology:Dragon Pharma announces 2007 full year financial results 2Dragon Pharma announces 2007 full year financial results 3Dragon Pharma announces 2007 full year financial results 4Dragon Pharma announces 2007 full year financial results 5Dragon Pharma announces 2007 full year financial results 6Dragon Pharma announces 2007 full year financial results 7Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008 2Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008 3Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008 4Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008 5Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008 6Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008 7New Capillary Column From Varian, Inc. Offers Durability and Performance for High Temperature GC and GC/MS 2
(Date:5/19/2015)... 19, 2015  Technology is rapidly advancing, outpacing enterprises, ... the cloud. Passwords and their management are soon to ... standards-based specifications such as those developed by the FIDO ... passwords presents for BYOD, COPE, IoT, and mobile payments, ... protocol. In response to the call ...
(Date:5/11/2015)... JOSE, Calif. , May 11, 2015 /PRNewswire/ ... developer of human interface solutions, today announced the ... Vice President and Chief Financial Officer, reporting to ... Ali replaces Synaptics, current Chief Financial Officer, ... December 2014. Mr. Ali brings ...
(Date:5/7/2015)... GOTHENBURG, Sweden , May 7, 2015 /PRNewswire/ ... new touch fingerprint sensors, FPC1022 and FPC1035, FPC,s ... FPC1022 and FPC1035 are mainly considered for integration ... decreased size gives smartphone OEMs increased possibilities to ... portfolio. The decreased size also improves possibilities for ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... of Connecticut and California State University researchers found that ... Stellwagen Bank National Marine Sanctuary showed indications of recovery ... stable. The finding is significant because bottom trawlers, dredges ... floor and benthic ecosystems that provide food and shelter ...
... microscope by removing the lens to create a system that ... hand but powerful enough to create three-dimensional tomographic images of ... in the early online edition of the journal Proceedings ... demonstration of lens-free optical tomographic imaging on a chip, a ...
... Scotland,s first fully protected marine reserve, and only the ... conservation benefits, according to new research. , After only ... signs for both fishermen and conservationists, according to a ... of Arran Seabed Trust (COAST). , The research, published ...
Cached Biology News:Optical microscope without lenses produces high-resolution 3-D images on a chip 2Optical microscope without lenses produces high-resolution 3-D images on a chip 3Scotland's first marine reserve already producing benefits 2